Ajna Biosciences CEO Joel Stanley discusses the differences between botanical drugs and botanically-derived drugs.
Joel Stanley
Advertisement
Articles by Joel Stanley
In many plants, the full expression of therapeutic value only emerges when their components are allowed to work in concert.
Advertisement
Latest Updated Articles
How the Entourage Effect Is Reshaping Botanical Drug DevelopmentPublished: July 31st 2025 | Updated: August 5th 2025
Advertisement
Advertisement
Trending on PharmExec
1
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
2
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
3
Pharmaceutical Executive Daily: Novo Nordisk Commits $506 Million to Ireland Manufacturing Site
4
The Multi-Purpose Paradigm: Scaling AI ROI and De-Risking the Life Sciences Value Chain
5